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INTRODUCTION
Children with cerebral palsy (CP) are at risk for respiratory 
dysfunction due to various causes, such as pneumonia, atel-
ectasis, bronchiectasis, sleep apnea, and chronic obstructive 
lung disease. Restrictive lung disease is also common in pa-
tients with CP.1,2 In addition, poor nutritional status, drooling, 
aspiration, gastroesophageal reflux, impairment of airway 
clearance due to muscular weakness or incoordination, and 
poor pulmonary reserve increase the risk of morbidity and 
mortality as a result of respiratory infection.3-8 According to a 
recently reported study, children with spastic CP have lower 
pulmonary function than normal, healthy children.9 Poor chest 
mobility, trunk extensibility, and weak respiratory muscle st-
rength are related to poor respiratory function in children with 
CP.3,10,11 
Incentive spirometer exercise (ISE) is widely used in chest 
physiotherapy, and it encourages the patient to perform slow 
and deep inspiration through visual feedback, allowing for the 
stretching and opening of collapsed airways. ISE is useful as it 
is inexpensive and simple to use with no known side effects, 
and also it does not require supervision once the child is tr-
ained in its use. Furthermore, achievement of the visual target 
encourages the children to try their best and thus promotes pa-
tient compliance.12 Previous reports demonstrated some ben-
eficial effects of ISE on pulmonary function and arterial blood 
gases in patients with chronic obstructive pulmonary disease,13-15 
as well as in patients with ankylosing spondylitis.12
According to a recently published study, feedback respira-
tory training (FRT) in children with CP leads to improvement 
in pulmonary function.16 However, there is still a paucity of data 
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regarding the effectiveness of respiratory training on pulmo-
nary function in children with CP.
Maximum phonation time (MPT) represents the ability to 
maximally sustain a vowel sound after having taken a maximal 
inspiration. It is widely used to evaluate the efficiency of respi-
ratory mechanisms during phonation, because it is a quick, non-
invasive, and inexpensive method. According to a previous 
report, MPT has been used to objectively assess the degree of 
severity of dysphonia and to determine the effects of voice th-
erapy.17 Additionally, it has proven to be a highly reliable mea-
sure in voice assessment.18 To the best of our knowledge, the 
effects of respiratory training on MPT have not yet been inves-
tigated in children with CP. 
Therefore, the aims of this study were to evaluate the effect 
of ISE on pulmonary function tests (PFT) and MPT in children 
with spastic CP. 
MATERIALS AND METHODS
This was a prospective, randomized, case-control study (reg-
istration number NCT02406404). Ethical approval was grant-
ed by the Institutional Review Board and ethics committee of 
Severance Hospital. Since all of the children in this study were 
younger than 18 years, informed consent was obtained from the 
parents of the children who agreed to participate in this study. 
Participants
This study was conducted in a rehabilitation hospital affiliated 
with a university between May 2013 and April 2015. Among the 
children who were admitted to our hospital for intensive ther-
apy, those who met the following inclusion and exclusion crite-
ria were selected for this study: the inclusion criteria included 
1) children with spastic CP between the ages of 8 and 15 years, 
2) level I to IV on the Gross Motor Function Classification Sys-
tem (GMFCS), who have the ability to maintain antigravity head 
and trunk postures, 3) cognitive and cooperative function al-
lowing for pulmonary function measurements, and 4) no his-
tory of psychiatric or neurological disorders other than CP. The 
exclusion criteria included 1) any uncontrolled, clinically sig-
nificant medical condition, such as coexistent cardiac disease 
or respiratory disease, 2) children with cognitive impairment 
who are unable to comply with the protocol-required proce-
dure, 3) children with the presence or history of tracheostomy, 
4) children who are taking medications that can affect respira-
tory function, and 5) children with bone deformities of the 
spine, such as kyphosis or scoliosis. As a result, 60 children 
met the criteria, and 10 eligible participants declined to partici-
pate in the study. Thus, 50 children participated in this study. 
A computerized random generator was used to assign each par-
ticipant to the experimental group (n=25) or the control group 
(n=25) (Fig. 1). 
Study design
Participants in the experimental group were treated using a 
flow-oriented incentive spirometer (DHD CliniFLO®, Smiths 
medical ASD, Inc., Rockland, MA, USA) (Fig. 2), which has a ch-
amber-containing ball. The ball is raised in its chamber upon 
generation of different inspiratory flow rates (six flow settings 
from 100 mL/sec to 600 mL/sec) by participants breathing 
Fig. 1. Flow chart of participant enrollment.
Screened (n=60)
Randomized (n=50)
Conventional exercise+
incentive spirometer exercise completers (n=25)
Conventional exercise+
incentive spirometer exercise (n=25)
Conventional exercise completers (n=23)
Conventional exercise (n=25)
Two were excluded
due to follow-up loss
Consent withdrawn (n=10)
Fig. 2. Incentive spirometer (DHD CliniFLO®).
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through a mouthpiece. The children in the ISE group were inst-
ructed on how to use the incentive spirometer. After a quiet ex-
piration, they were encouraged to close their lips tightly around 
the mouthpiece and then inhale slowly and deeply until the 
ball in the spirometer lifted. They were then instructed to hold 
their breath for as long as possible, or for at least 5 seconds, 
and then to breathe out slowly. Corresponding to the inspira-
tory flow, the balls lifted and remained suspended by the sus-
tained inspiratory flow, which served as visible feedback. The 
flow rate progressively increased at 100 mL/sec intervals from 
100 mL/sec to 600 mL/sec, if the participants could maintain 
the balls lifted at least 5 seconds. 
The participants were encouraged to use the device for 10–
15 breaths per session. Ten training sessions were performed 
daily for 4 weeks. They trained themselves with checklist in a 
hospital room with regular supervision twice a week. Children 
in both groups received conventional physical therapy and oc-
cupational therapy that focused on gross and fine motor tasks 
five times per week for a period of four weeks. 
Outcome measures
The Gross Motor Function Measure (GMFM)-66 was used to 
assess improvement in gross motor function. GMFM-66 has 
been shown to be a reliable and valid measure of gross motor 
function and useful for measuring the effect of intervention 
programs.19 
The PFT was done in the resting period at least 1 hour after 
physical and occupational therapy and ISE. The PFT was per-
formed before training and at the end of the 4-week training 
period by the same investigator. PFT was performed using a 
portable spirometer (Micro Spirometer MS01; Micro Medical 
Ltd., Kent, UK) assessing forced expiratory volume at one sec-
ond (FEV1) and forced vital capacity (FVC). A peak flow meter 
(ASSESS® Respironics International Inc., Murrysville, PA, USA) 
was also used to measure peak expiratory flow (PEF). The chil-
dren were seated on a chair with the head and trunk straight 
and the hip and knee joints flexed to 90° with use of external 
supporting pad. For the children at GMFCS level IV, the test was 
performed in a chair sitting with external supporting pad and 
also the shoulder supported by their parent’s hands. We used 
Table 1. Demographic and Baseline Characteristics of the Control Group and the Incentive Spirometer Treatment Group
Control group (n=23) ISE group (n=25) p value*
Age (yrs) 11.7 (2.5) 11.4 (2.3) 0.72 
Gender, male (%) 11 (47.8) 15 (60.0) 0.40 
Gestational age (wks) 33.3 (4.4) 32.8 (4.0) 0.60
Birth weight (kg) 2.1 (0.9) 2.0 (0.8) 0.49
Height (cm) 139.8 (16.2) 141.2 (13.4) 0.75
Weight (kg) 38.1 (12.3) 39.9 (14.9) 0.65
Body mass index (kg/m2) 19.1 (3.7) 19.4 (4.6) 0.80
GMFCS >0.99
I 2 (8.7) 2 (8.0)
II 7 (30.4) 8 (32.0)
III 12 (52.2) 12 (48.0)
IV 2 (8.7) 3 (12.0)
Topography classification 0.78
Diplegia 17 (73.9) 20 (80.0)
Hemiplegia 3 (13.1) 1 (4.0)
Triplegia 2 (8.7) 3 (12.0)
Quadriplegia 1 (4.3) 1 (4.0)
Pulmonary function tests
FEV1 (L) 1.4 (0.4) 1.4 (0.4) 0.62
FEV1 (% predicted) 84.4 (21.8) 81.9 (25.2) 0.72
FVC (L) 1.9 (0.7) 1.9 (0.5) 0.96
FVC (% predicted) 86.2 (21.0) 84.3 (21.0) 0.75
FEV1/FVC (%) 71.7 (17.2) 72.8 (11.9) 0.81
Peak expiratory flow (L/min) 185.7 (60.1) 191.6 (56.2) 0.51
Maximal phonation time (sec) 9.7 (5.3) 10.2 (3.7) 0.71
GMFM-66 (%) 57.9 (24.0) 53.8 (24.9) 0.58
ISE, incentive spirometry exercise; GMFCS, Gross Motor Function Classification System; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 sec; GMFM, 
Gross Motor Function Measure.
Values are expressed as mean (SD) or number of participants (percentage). 
*p-values were calculated by independent t-tests or Mann-Whitney test or chi-square tests.
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various chairs in consideration of each child’s size. The chil-
dren were told to inhale as deeply as possible and to blow their 
entire lung volume through the spirometer. This process was 
repeated at least three times, and the highest value was select-
ed. PFT data were normalized for age, gender, and height, and 
the predicted FEV1 and FVC values (%) were calculated using 
the equations provided by Yoon, et al.20 based on values acqu-
ired from healthy Korean children. These calculations were 
used to obtain percent predicted values for FVC (FVC, %) and 
FEV1 (FEV1, %). 
Maximal phonation time (MPT) testing was conducted in a 
quiet room with children seated on a chair in the same body 
position with measurement of PFT. The children were asked 
to inhale deeply and then produce a sustained phonation of 
the vowel /a:/ at a comfortable pitch and loudness in the seated 
position for as long as possible. The children were allowed three 
trials in a row with a 30-second break in between. Each pho-
nation was video recorded (Handycam DCR-SR67; Sony Co., 
Tokyo, Japan), and the longest value was used for analysis. 
Statistical analysis
The baseline characteristics of the two groups were compared 
using the Student’s t-test or Mann-Whitney test for continuous 
variables and the chi-square test for categorical variables. Com-
parisons of pulmonary function before and after training within 
each group were made using the paired samples t-test or Wil-
coxon signed rank test. Differences between the experimental 
group and the control group were assessed using an indepen-
dent samples t test or Mann-Whitney test. Statistical software 
SPSS 20.0 (SPSS Inc., Chicago, IL, USA) was used for statistical 
analysis. The level of significance was chosen to be 0.05. 
RESULTS 
Although 50 children with CP were recruited for the study, two 
children in the control group did not complete the study pro-
tocol due to early discharge. As a result, 25 children in experi-
mental group and 23 children in control group were included 
in this study. Their mean age was 11.6 years old (±2.3 years). 
The demographic and baseline characteristics of the study 
population are shown in Table 1. The two groups were not sig-
nificantly different in gestational age, birth weight, height, or 
body weight. The PFT parameters and GMFM scores at base-
line were not significantly different between the two groups. 
FEV1, FVC, PEF, and MPT increased significantly after ISE in 
the experimental group, compared with baseline data. The im-
provements in FEV1, FVC, and MPT were significantly higher 
in the experimental group than in the control group (Table 2). 
Compared to baseline GMFM-66 scores, GMFM scores sig-
nificantly increased after 4 weeks of training in both groups, al-
though improvements in the GMFM scores were not signifi-
cantly different between the two groups. 
There were no significant relationships between GMFM-66 
scores and PFT parameters, such as FEV1, FVC and PEF, but 
significant correlation with MPT (Table 3); and also the im-
provements in GMFM-66 scores did not significantly relate to 
changes in pulmonary function or MPT. 
DISCUSSION 
The FEV1, FVC, and FEV1/FVC ratio are useful parameters for 
assessing restrictive lung disease. On the other hand, PEF is a 
measure of the maximal or peak flow produced during exha-
lation with maximal effort, and it assesses maximal expiratory 
effort as a surrogate measure for expiratory muscle strength 
and is useful for assessing obstructive lung disease, such as 
asthma. These parameters are considered to be potentially 
very useful in integrated measures of respiratory function in 
Duchenne muscular dystrophy patients.21 In addition, previ-
ous studies have shown that pulmonary function in the chil-
dren with CP had characteristics of both obstructive and re-
strictive lung disease,2,22-25 and thus, FEV1, FVC, and PEF were 
Table 2. Comparison of Pre- and Post-Treatment Measurements in the Control Group and the Incentive Spirometer Treatment Group
Parameters
Control group (n=23) ISE group (n=25) Between
group pBaseline Wk 4 p value Baseline Wk 4 p value
FEV1 (L) 1.35 (0.44) 1.35 (0.45) 0.848 1.40 (0.37) 1.57 (0.44)* 0.005 0.017†
FEV1 (% predicted) 84.42 (21.78) 85.59 (24.15) 0.605 81.91 (25.20) 91.12 (28.24)* 0.009 0.036†
FVC (L) 1.94 (0.66) 1.90 (0.69) 0.511 1.95 (0.48) 2.15 (0.56)* 0.000 0.005†
FVC (% predicted) 86.19 (20.95) 83.31 (18.44) 0.685 84.25 (21.03) 92.18 (24.98)* 0.001 0.031†
FEV1/FVC (%) 71.71 (17.23) 73.79 (15.68) 0.563 72.76 (11.91) 74.48 (13.98) 0.443 0.821
PEF (L/min) 185.65 (60.14) 194.78 (55.40) 0.473 191.60 (56.25) 217.60 (67.58)* 0.003 0.085
MPT (sec) 9.65 (5.30) 10.06 (5.75) 0.705 10.16 (3.70) 12.13 (3.61)* 0.001 0.008†
GMFM-66 (%) 57.92 (23.97) 61.58 (24.24)* 0.003 53.83 (24.93) 57.37 (23.34)* 0.001 0.916
ISE, incentive spirometry exercise; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 sec; PEF, peak expiratory flow; MPT, maximal phonation time; 
GMFM, Gross Motor Function Measure.
Values are expressed as means (SD).
*p<0.05 by paired samples t-test or Wilcoxon signed rank test, baseline versus after four weeks within each group, †p<0.05 by independent samples t-test or 
Mann-Whitney test, comparisons of pre- and post-test differences in pulmonary function between the experimental group and the control group. 
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assessed as outcome measures in this study.
Shallow breathing, paradoxical breathing, and low breath-
ing volume are commonly noted in children with CP, particu-
larly low functioning CP, and these findings may lead to the 
development of widespread microatelectasis and a decrease 
in lung distensibility.26,27 Morbidity and mortality associated 
with CP is mainly related to respiratory compromise, especially 
in low functioning CP. Therefore, interventions for enhancing 
respiratory function should be included as part of the compre-
hensive management for children with CP.
Some previous studies, report positive effects of various ex-
ercise programs on vital capacity (VC).11,24,27 However, the ef-
fect of respiratory training in children with CP has rarely been 
reported. In a previous randomized controlled study by Lee, 
et al.,16 FRT led to significant gains in FEV1 and FVC, but not in 
PEF. In that study, the FRT group consisted of only nine chil-
dren, and thus, the improvement in PEF after FRT did not reach 
a statistically significant level. On the other hand, our random-
ized controlled study revealed significant improvements in 
FEV1, FVC, and PEF after ISE training. FRT consists of repetitive, 
continuous performance of both maximal inspiration and ex-
piration training, while ISE is designed to achieve and sustain 
maximal inspiration for a prolonged period using slow inspi-
ration and deep breaths.16,28,29 Although there are some differ-
ences between FRT and ISE, both ISE and FRT are effective in 
enhancing pulmonary function. The ISE, which increases 
transpulmonary pressure, inspiratory volumes, and inspiratory 
muscle performance, by encouraging the patient to take long, 
slow, deep breaths,30 led to improvement in these parameters. 
The results of our study suggest that ISE is useful for enhanc-
ing both inspiratory and expiratory muscle strengthening. 
According to another previous study by Kwon and Lee,9 the 
children at GMFCS level III had a higher gain in FVC after FRT 
than the children at GMFCS level I or II.31 They suggested that 
children at GMFCS level I or II may have already reached the 
upper level of their respiratory function capacity, and thus, 
their improvement is not significant after FRT. The normal val-
ues of FVC and FEV1 can vary depending on various factors 
such as height, weight, and sex, and thus, predicted values (%) 
for FVC or FEV1 are preferred to compare the results across 
studies. In Kwon and Lee9 and Lee, et al.’s16 previous studies, 
predicted values for FVC and FEV1 were not assessed. In addi-
tion, the responses of respiratory training on pulmonary func-
tion in children with CP may differ between unilateral CP and 
bilateral CP. Further studies are needed to determine the best 
candidates for respirator training. 
Respiration is an essential physiologic component for main-
taining vital function and for performing physical activity in 
daily life.32 Respiration is also one of the key elements of phys-
ical fitness, along with muscular function and cardiovascular 
function.33 A recent study pointed out that respiratory muscle 
strength in children with CP is positively correlated with the 
activities of daily living, self-care, and social function.10 From 
this perspective, it is interesting to note whether improvement 
in respiratory function can lead to better exercise endurance, 
perception of dyspnea, and quality of life. Further studies to 
address this issue may be helpful for understanding the role of 
respiratory exercise in children with CP. 
According to a previous study, MPT increases in normal chil-
dren as they grew older, and MPT of normal children in the 
United States at the age of 8 to 15 years is between 17.1 and 
20.7 sec.34 On the other hand, MPT of normal Korean children 
aged from 8 to15 years reportedly range from 12.6 to 15.8 sec.35 
Compared to those values, the MPTs of our children are short-
er. In a previous study, children with spastic CP had a shorter 
MPT than the normal control group.36 Also, a significant posi-
tive correlation between MPT and peak VO2 and also between 
MPT and the severity of chronic heart failure (CHF) were re-
ported in patients with CHF.37,38 On the other hand, there was 
no significant relationship between MPT and VC in adults 
with normal speech and voice.39 The proportion of VC used by 
individual speakers for the MPT task can vary, leading to no 
significant relationship between VC and MPT.40-42 Also, in our 
study, there were no significant relationships between MPT 
and the parameters of PFT. ISE is a breathing technique in 
which deep breathing exercises are performed through a de-
vice that offers visual feedback in response to inspired flow 
and volume. These exercises allow patients to maximally inflate 
their lungs and to sustain that inflation. Thus, through this ex-
ercise, improvement in breath control appears to result in the 
observed increase in MPT. Breathy speech, weak breath con-
trol, and short utterances are major speech and voice concerns 
in children with CP.43 The results of our study suggest that ISE 
may be helpful for enhancing breath control for speech pro-
Table 3. Pearson Correlation Coefficients between Gross Motor Func-
tion Measure (GMFM) and Pulmonary Function Tests
Correlation p value
Baseline GMFM-66 in the whole group (%)
FEV1 (L) 0.190 0.216
FVC (L) 0.214 0.164
PEF (L/min) 0.140 0.363
MPT (sec) 0.462* 0.003
GMFM difference in the ISE group (n=25)
FEV1 (L) difference -0.132 0.529
FVC (L) difference -0.094 0.655
PEF (L/min) difference 0.141 0.500
MPT (sec) difference 0.205 0.325
GMFM difference in the control group (n=23)
FEV1 (L) difference -0.291 0.177
FVC (L) difference -0.253 0.245
PEF (L/min) difference -0.123 0.577
MPT (sec) difference 0.011 0.960
ISE, incentive spirometry exercise; FVC, forced vital capacity; FEV1, forced ex-
piratory volume in 1 sec; PEF, peak expiratory flow; MPT, maximal phonation 
time.
*Correlation is significant at the 0.05 level.
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duction in children with CP. Further studies are needed to de-
lineate the clinical relevance of the improvement in MPT in 
terms of speech and voice quality in children with CP.
There are some limitations of our study. Most of children of 
our study were at level II or III, and thus, the effects of ISE ac-
cording to GMFCS level were not investigated in our study. Fur-
ther studies are needed to outline optimal candidates for ISE 
in terms of GMFCS level. Another limitation comes from the 
duration of respiratory training. According to a previous re-
port,16 significant improvements in pulmonary function were 
obtained with 4 weeks of respiratory training in children with 
CP. Four weeks is the maximal duration of stay in our hospital 
in general, and thus, 4 weeks of respiratory training was se-
lected for our study. However, the optimal duration of training 
in order to maximize pulmonary function needs to be clari-
fied in children with CP through further studies.
In conclusion, this randomized controlled study demon-
strated significant benefits of ISE in terms of pulmonary func-
tion and MPT in children with spastic CP. ISE is a simple and 
inexpensive tool for children to use, and therefore, wider use of 
ISE may be helpful for children at risk of pulmonary dysfunc-
tion and poor breath control in speech production.
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